EP Patent

EP0248634A2 — Stabilized benzimidazole derivative and composition

Assigned to Nippon Chemiphar Co Ltd · Expires 1987-12-09 · 38y expired

What this patent protects

A stabilized physiologically active benzimidazole derivative having the formula (I): wherein R¹ is hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a fluoroalkyl group having 1 to 6 carbon atoms, a cycloalkyl group, phenyl group or an aralkyl group, R² is hydrogen …

USPTO Abstract

A stabilized physiologically active benzimidazole derivative having the formula (I): wherein R¹ is hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a fluoroalkyl group having 1 to 6 carbon atoms, a cycloalkyl group, phenyl group or an aralkyl group, R² is hydrogen atom or a lower alkyl group, or R¹ and R² together with the adjacent nitrogen atom form a ring, and each of R 3a , R 3b , R 4a , R 4b and R 4c independ­ently is hydrogen atom, a halogen atom, a flouroalkyl group having 1 to 6 carbon atoms, a lower alkyl group, a lower alkoxy group, a lower alkoxycarbonyl group or an amino group. The stabilized benzimdazole derivative is in amorphous form or present in contact with a basic material.

Drugs covered by this patent

Patent Metadata

Patent number
EP0248634A2
Jurisdiction
EP
Classification
Expires
1987-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Nippon Chemiphar Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.